C2CD4C | C2 calcium-dependent domain containing 4C | | | | | | Group enriched |
CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Group enriched |
RP11-763F8.1 | Uncharacterized protein | | | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AC018867.2 | | Predicted membrane proteins
| | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
BCL2L15 | BCL2-like 15 | | | | | | Group enriched |
C12orf36 | Chromosome 12 open reading frame 36 | | | | | | Group enriched |
C14orf105 | Chromosome 14 open reading frame 105 | | | | | | Group enriched |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CES5A | Carboxylesterase 5A | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DEFB4A | Defensin, beta 4A | Predicted secreted proteins Transporters
| | | | | Group enriched |
DEFB4B | Defensin, beta 4B | Predicted secreted proteins Transporters
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GDF6 | Growth differentiation factor 6 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
GLYATL2 | Glycine-N-acyltransferase-like 2 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
LYPD6B | LY6/PLAUR domain containing 6B | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
NXF3 | Nuclear RNA export factor 3 | | | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PPP1R1C | Protein phosphatase 1, regulatory (inhibitor) subunit 1C | | | | | | Group enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
RP11-167N24.6 | Uncharacterized protein | | | | | | Group enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM92 | Transmembrane protein 92 | Predicted membrane proteins
| | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
UGT2B11 | UDP glucuronosyltransferase 2 family, polypeptide B11 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
VNN1 | Vanin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |